Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Circulation

• Publication date

  1997-09-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.CIR.96.5.1593PMID 9315552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension.

  1997cited by this paper
• Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril.

  1996cited by this paper
• Vascular remodeling.

  1996cited by this paper
• Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats.

  1996cited by this paper
• Receptor Selectivity of Endothelin Antagonists and Prevention of Vasoconstriction and Endothelin‐Induced Sudden Death

  1995cited by this paper
• Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.

  1995cited by this paper
• Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition.

  1995cited by this paper
• Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist.

  1995cited by this paper
• Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.

  1994cited by this paper
• Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme.

  1994cited by this paper
• Textbook of hypertension

  1994cited by this paper
• Small artery structure in hypertension. Dual processes of remodeling and growth.

  1993cited by this paper
• Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats.

  1993cited by this paper
• Cerebral vascular changes during chronic hypertension: good guys and bad guys.

  1992cited by this paper
• Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries.

  1992cited by this paper
• Induction of Endothelin‐1 Gene by Angiotensin and Vasopressin in Endothelial Cells

  1992cited by this paper
• Endothelin stimulates protein synthesis in smooth muscle cells.

  1992cited by this paper
• Angiotensin II Causes Vascular Hypertrophy in Part by a Non‐pressor Mechanism

  1991cited by this paper
• Endothelin is a potent mitogen for rat vascular smooth muscle cells.

  1989cited by this paper
• Remodeling of Cerebral Arterioles in Chronic Hypertension

  1989cited by this paper
• Some Statistical Methods Useful in Circulation Research

  1980cited by this paper

• Effects of Cytokines (or Activating Factors) on Arterial Endothelial Cells

  2025cites this paper
• Role of Vasoactive Hormone-Induced Signal Transduction in Cardiac Hypertrophy and Heart Failure

  2024cites this paper
• Experimental Induction of Intracranial Aneurysms in Rats: A New Model Utilizing a Genetic Modification within the EDNRA Gene

  2022cites this paper
• The Disease-Modifying Role of Taurine and Its Therapeutic Potential in Coronavirus Disease 2019 (COVID-19).

  2022cites this paper
• Endothelial Barrier Function and Leukocyte Transmigration in Atherosclerosis

  2021cites this paper
• Mechanisms of Herbal Nephroprotection in diabetes mellitus

  2020cites this paper
• Endothelin-targeted new treatments for proteinuric and inflammatory glomerular diseases: focus on the added value to anti-renin-angiotensin system inhibition

  2020cites this paper
• Deletion of the myeloid endothelin-B receptor confers long-term protection from angiotensin II-mediated kidney, eye and vessel injury

  2020cites this paper
• The endothelin system as target for therapeutic interventions in cardiovascular and renal disease.

  2020cites this paper
• The role of CFTR in normal human lung microvascular endothelial cells

  2019cites this paper
• A novel role for myeloid endothelin-B receptors in hypertension

  2019influential citation
• Endothelin: 30 Years From Discovery to Therapy.

  2019cites this paper
• MiR-21, MiR-29a, GATA4, and MEF2c Expression Changes in Endothelin-1 and Angiotensin II Cardiac Hypertrophy Stimulated Isl-1+Sca-1+c-kit+ Porcine Cardiac Progenitor Cells In Vitro

  2019cites this paper
• Favorable Vascular Actions of Angiotensin-(1–7) in Human Obesity

  2018cites this paper
• Chronic ETA antagonist reverses hypertension and impairment of structure and function of peripheral small arteries in aortic stiffening

  2018cites this paper
• Tauroursodeoxycholic acid (TUDCA) abolishes chronic high salt‐induced renal injury and inflammation

  2018cites this paper
• Beneficial Effects of Apelin on Vascular Function in Patients With Central Obesity

  2017cites this paper
• Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials.

  2017cites this paper
• Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation.

  2017cites this paper
• Cyclooxygenase-2 Inhibition Limits Angiotensin II-Induced DNA Oxidation and Protein Nitration in Humans

  2017cites this paper
• Plasma ET-1 Concentrations are Elevated in Patients with Hypertension – Meta-Analysis of Clinical Studies

  2017cites this paper
• Long-term neprilysin inhibition — implications for ARNIs

  2017cites this paper
• Role of CaMKII in Ang-II-dependent small artery remodeling.

  2016cites this paper
• The Role Of T Cells In Postmenopausal Hypertension

  2016cites this paper
• hypertension in mice hyperbilirubinemia and attenuates ANG II-dependent Inhibition of bilirubin metabolism induces moderate

  2016cites this paper
• A novel hydrodynamic approach of drag-reducing polymers to improve left ventricular hypertrophy and aortic remodeling in spontaneously hypertensive rats

  2016cites this paper
• Pressure distension in leg vessels as influenced by prolonged bed rest and a pressure habituation regimen.

  2016cites this paper
• Maternal high-salt diets affected pressor responses and microvasoconstriction via PKC/BK channel signaling pathways in rat offspring.

  2015cites this paper
• Therapieresistente Hypertonie: Ursachen und pharmakologische und nichtpharmakologische Therapie

  2015cites this paper
• Endothelin-1 Antagonist in the Management of Refractory Systemic Hypertension in Children with End Stage Kidney Disease: A Case Series

  2014cites this paper
• Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes

  2014cites this paper
• Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain

  2014cites this paper
• ROLE OF APELIN AND ENDOTHELIN SYSTEMS IN THE PAIN ASSOCIATED WITH SICKLE CELL DISEASE

  2014cites this paper
• Endothelin-1 but not angiotensin II contributes to functional aging in murine carotid arteries.

  2014influential citation
• Utility of C-terminal proendothelin in the early diagnosis and risk stratification of patients with suspected acute myocardial infarction.

  2014cites this paper
• Pulmonary Hypertension and Cardiopulmonary Exercise in Heart Failure

  2014cites this paper
• Charakterisierung eines transgenen Rattenmodells mit Koexpression des humanen Endothelin-B Rezeptors im glatten Gefäßmuskel

  2014cites this paper
• Inhibition of endothelin A receptor protects brain microvascular endothelial cells against hypoxia‑induced injury.

  2014cites this paper
• Blood pressure regulation V: in vivo mechanical properties of precapillary vessels as affected by long-term pressure loading and unloading

  2013cites this paper
• Elevations of local intravascular pressures release vasoactive substances in humans

  2013cites this paper
• Angiotensin II-mediated vascular changes in aged offspring rats exposed to perinatal nicotine.

  2013cites this paper
• saphenous veins Endothelin blockade potentiates endothelial protective effects of ace inhibitors in

  2013cites this paper
• Endothelin Receptor Antagonists in Heart Failure

  2012cites this paper
• Pulmonary hypertension in canine degenerative mitral valve disease.

  2012cites this paper
• Renoprotective effects of (+)-catechin in streptozotocin-induced diabetic rat model.

  2012cites this paper
• Overview of Animal Models

  2012cites this paper
• Effects of Melatonin on The Tissue Factor Activities of Kidney, Heart and Brain in Experimental Renovascular Hypertension

  2012cites this paper
• Endothelium-derived vasoactive agents, AT1 receptors and inflammation.

  2011cites this paper
• Changes critical to persistent lowering of arterial pressure in spontaneously hypertensive rat occur early in antihypertensive treatment

  2011cites this paper
• ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells.

  2011cites this paper
• Biomarkers of Left Ventricular Hypertrophy and Remodeling in Blacks

  2011cites this paper
• Differential roles of endothelin-1 in angiotensin II-induced atherosclerosis and aortic aneurysms in apolipoprotein E-null mice.

  2011cites this paper
• Endothelial Regulation of Pulmonary Vascular Tone

  2011cites this paper
• Protective Effect of Tongxinluo on Oxidative Injury Induced by Angiotensin II in Rats

  2011cites this paper
• Contrasting effects of intervention with ET A and ET B receptor antagonists in angiotensin II-high salt diet induced hypertension

  2011cites this paper
• Renal hemodynamics in renal artery stenosis and angiotensin II-dependent hypertension. Pathophysiological and diagnostic aspects.

  2011cites this paper
• Lisinopril inhibits endothelin-1 in the early period of hepatic reperfusion injury in a partial hepatectomy model.

  2011cites this paper
• Oxidative Stress and Endothelin-1 in Atherosclerotic Renal Artery Stenosis and Effects of Renal Angioplasty

  2011cites this paper
• Angiotensin-(1-7): A peptide hormone inhibitor for the treatment of breast cancer targeting the tumor microenvironment

  2010cites this paper
• Metabolic regulation of coronary vascular tone: role of hydrogen peroxide, purinergic components, and angiotensin.

  2010cites this paper
• Contrasting effects of intervention with ETA and ETB receptor antagonists in hypertension induced by angiotensin II and high-salt diet.

  2010cites this paper
• The Renin-Angiotensin System in the Development of Salt-Sensitive Hypertension in Animal Models and Humans

  2010cites this paper
• Endothelin

  2010cites this paper
• Rosiglitazone reverses cardiac adverse remodeling (fibrosis and vascularization) in perinatal low protein rat offspring.

  2010cites this paper
• At the heart of tissue: endothelin system and end-organ damage.

  2010cites this paper
• Expression von Genen des Endothelin-, Renin-Angiotensin- und Stickstoffmonoxidsystems in Mäusen mit Endothelin-Typ B-Rezeptor-Defizit

  2010cites this paper
• Distensibility in Arteries, Arterioles and Veins in Humans : Adaptation to Intermittent or Prolonged Change in Regional Intravascular Pressure

  2010cites this paper
• Role of pro-inflammatory and homeostatic chemokines in diabetic nephropathy

  2010cites this paper
• Actions of selected cardiovascular hormones on arterial stiffness and wave reflections.

  2009cites this paper
• Les récepteurs intracellulaires de l'angiotensine II: nouvelles cibles thérapeutiques pour le remodelage cardiaque

  2009cites this paper
• Regulation of coronary vascular tone via redox modulation in the alpha1-adrenergic-angiotensin-endothelin axis of the myocardium.

  2009cites this paper
• Angiotensin II‐induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart

  2009cites this paper
• Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice.

  2009cites this paper
• Endothelin as a Clinical Target in the Treatment of Systemic Hypertension

  2009cites this paper
• Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure

  2009cites this paper
• ROLE OF ENDOTHELIN-1 IN THE REGULATION OF THE SWELLING-ACTIVATED Cl- CURRENT IN ATRIAL MYOCYTES

  2009cites this paper
• Synergistic co‐operation of signal transducer and activator of transcription 5B with activator protein 1 in angiotensin II‐induced angiotensinogen gene activation in vascular smooth muscle cells

  2009cites this paper
• Endothelin receptor antagonists as antihypertensives: the next frontier

  2009cites this paper
• Endothelin-1 induces intracellular [Ca2+] increase via Ca2+ influx through the L-type Ca2+ channel, Ca2+-induced Ca2+ release and a pathway involving ETA receptors, PKC, PKA and AT1 receptors in cardiomyocytes

  2009cites this paper
• Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence

  2009cites this paper
• Assessment of effect of angiotensin II receptor antagonist losartan on aortic distensibility in patients with essential hypertension by echocardiography

  2008cites this paper
• Endothelin-1, aging and hypertension

  2008cites this paper
• Efficacy and Safety of Darusentan: A Novel Endothelin Receptor Antagonist

  2008cites this paper
• Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides

  2008cites this paper
• Papel do sistema endotelina na nefropatia diabética

  2008cites this paper
• Regulation of coronary vascular tone via redox modulation in the alpha1-adrenergic-angiotensin-endothelin axis of the myocardium

  2008cites this paper
• Preglomerular and postglomerular basal diameter changes and reactivity to angiotensin II in obese rats

  2008cites this paper
• [Endothelin system function in diabetic nephropathy].

  2008cites this paper
• Endothelin contributes differently to peripheral vascular tone and blood pressure in human obesity and diabetes.

  2008cites this paper
• Functional and Structural Adaptations of Coronary Microvessels Distal to a Chronic Coronary Artery Stenosis

  2008cites this paper
• Tetramethylpyrazine inhibits angiotensin II-increased NAD(P)H oxidase activity and subsequent proliferation in rat aortic smooth muscle cells.

  2007cites this paper
• Endothelin-receptor antagonists in arterial hypertension: Further indications?

  2007cites this paper
• ACE Inhibition in Heart Failure and Ischaemic Heart Disease

  2007cites this paper
• Vasoactive peptides in cardiovascular (patho)physiology

  2007cites this paper
• Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation.

  2007cites this paper
• Comparative interaction of few antihypertensive drugs with cyclosporine-A in rats.

  2007cites this paper
• Activation of Endothelin-A Receptors Contributes to Angiotensin-Induced Suppression of Renal Sensory Nerve Activation

  2007cites this paper
• Effect of chronic IL-6 infusion on acute pressor responses to vasoconstrictors in mice.

  2007cites this paper
• Hypertension and SNP genotyping in antihypertensive treatment

  2007cites this paper
• Angiotensin II and Inflammation

  2007cites this paper